EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

All-in-one AAV-mediated Nrl gene inactivation rescues retinal degeneration in Pde6a mice

Zhiquan Liu, Siyu Chen, Chien-Hui Lo, Qing Wang, Yang Sun

JCI Insight · 2024

DOI: 10.1172/jci.insight.178159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, 2024. Verfasst von Zhiquan Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA. Hauptthemen laut MEDLINE: Cyclic Nucleotide Phosphodiesterases, Type 6, Dependovirus, Genetic Therapy, Retinal Degeneration. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, NEI NIH HHS, National Eye Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinitis pigmentosa (RP) is a complex group of inherited retinal diseases characterized by progressive death of photoreceptor cells and eventual blindness. Pde6a, which encodes a cGMP-specific phosphodiesterase, is a crucial pathogenic gene for autosomal recessive RP (RP43); there is no effective therapy for this form of RP. The compact CRISPR/Staphylococcus aureus Cas9 (CRISPR/SaCas9) system, which can be packaged into a single adeno-associated virus (AAV), holds promise for simplifying effective gene therapy. Here, we demonstrated that all-in-one AAV-SaCas9-mediated Nrl gene inactivation can efficiently prevent retinal degeneration in a RP mouse model with Pde6anmf363/nmf363 mutation. We screened single-guide RNAs capable of efficiently editing the mouse Nrl gene in N2a cells and then achieved effective gene editing by using a single AAV to codeliver SaCas9 and an optimal Nrl-sg2 into the mouse retina. Excitingly, in vivo inactivation of Nrl improved photoreceptor cell survival and rescued retinal function in treated Pde6a-deficient mice. Thus, we showed that a practical, gene-independent method, AAV-SaCas9-mediated Nrl inactivation, holds promise for future therapeutic applications in patients with RP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclic Nucleotide Phosphodiesterases, Type 6DependovirusGenetic TherapyRetinal DegenerationGene EditingDisease Models, AnimalEye ProteinsAnimalsMiceCRISPR-Cas SystemsRetinitis PigmentosaRetinaHumansMutationBasic-Leucine Zipper Transcription Factors

Stichwörter der Autor:innen

Gene therapyGenetic diseasesOphthalmologyTherapeutics

Substanzen

Cyclic Nucleotide Phosphodiesterases, Type 6Eye ProteinsNrl protein, mousePde6a protein, mouseBasic-Leucine Zipper Transcription Factors

Autor:innen und Institutionen

  • Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA.
  • Palo Alto Veterans Administration, Palo Alto, California, USA.

Förderung

  • CSRD VA
  • NEI NIH HHS
  • National Eye Institute

Zitieren

APA

Liu, Z., Chen, S., Lo, C. H., Wang, Q., & Sun, Y. (2024). All-in-one AAV-mediated Nrl gene inactivation rescues retinal degeneration in Pde6a mice. JCI Insight. https://doi.org/10.1172/jci.insight.178159

Vancouver

Liu Z, Chen S, Lo CH, Wang Q, Sun Y. All-in-one AAV-mediated Nrl gene inactivation rescues retinal degeneration in Pde6a mice. JCI Insight. 2024. doi:10.1172/jci.insight.178159

BibTeX
@article{Liu2024,
  author = {Liu, Zhiquan and Chen, Siyu and Lo, Chien-Hui and Wang, Qing and Sun, Yang},
  title = {All-in-one AAV-mediated Nrl gene inactivation rescues retinal degeneration in Pde6a mice},
  journal = {JCI Insight},
  year = {2024},
  doi = {10.1172/jci.insight.178159}
}
Kostenlos starten →